Anti-Cancer Drug | List of High Impact Articles | PPts | Journals | Videos
Journal of Cancer Science & Therapy
Search results for Anti-Cancer Drug
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Anti-cancer drugs are also called anti-neoplastic agents or chemotherapeutic agents. They act upon rapidly dividing cancer cells and destroy them. They can be used alone (single-drug therapy) or several at once (combination therapy). Various kinds of anti-cancer drugs are alkylating agents (cisplatin, chlorambucil, procarbazine, carmustine etc.), antimetabolites (methotrexate, cytarabine, gemcitabine etc.), anti-microtubule agents (vinblastine,paclitaxel etc.), topoisomerase inhibitors (etoposide, doxorubicin etc.), cytotoxic agents (bleomycin, mitomycin etc.). They have severe adverse effects like hair loss, nausea and vomiting, anemia etc.
Related Journals for Anti-cancer drugs:
Journal of Cancer science and Therapy, Cancer Surgery, Advances in Cancer Prevention, Archives in Cancer Research, Breast Cancer: Current Research, Recent Patents on Anti-Cancer Drug Discovery, Anti-Cancer Drugs Journal, Pharmacology of Anti-Cancer Drugs, Investigational New Drugs, Cancer Journals, Drug Development Journals, Anticancer Drug Development
Diane Paskiet Qualifi cation of extractables & leachables from container closure systems in drug products- Introduction to the Product Quality Institute (PQRI) recommendations PPT Version | PDF Version
Adel Nefzi âAdel Nefzi-Torrey-Pines-Institute-for-Molecular-Studies-USA-Diversity-Oriented-Synthesis-of-low-Molecular-Weight-Acyclic-and-Heterocyclic-Compounds-from-Resin-bound-Polyamides-Application-for-Drug-Discoveryâ PPT Version | PDF Version
Krasimira Pekova Have FDA expedited programs really shortened drug review time? an analysis of newly approved therapies and how FDA expedited programs have impacted drug development timelines PPT Version | PDF Version